American Superconductor Corporation (NASDAQ:AMSC), a current swing of ours, has been phenomenal, up seven day, and again on Monday, popping 77 cents, or 7.7%, to 10.77, on 428,547 shares traded. It formed a wedge, held support, reversed, and on Monday, it reached my target. If it backs and fills, and sets up again, we could see more upside. The secondary target is 12 1/4.
Exelixis Inc (NASDAQ:EXEL) continues to break out after the breakaway gap and retest, from the reverse head-and-shoulders or extended V. Over the last three weeks it has moved from 15 1/2 to 21 ½, and I think we’re going to see a quick test of 22 fairly soon. If it gets through that, my target is 25-26.
TAL Education Group (NYSE:TAL) jumped 1.38, or 5%, to 29.45, on 6.6 million shares. I put a swing on it on Monday because, when I see a declining channel, a breakout, moving averages crossing over, it consolidates, and then breakouts, that’s my buy point. Watch in the next few days going forward, it will get through 30-40. My targets are 35-40 going forward.
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) had a spectacular day on Monday on good drug results, jumping 6.43, or 26%, to 31.47, on 3.9 million shares. That was a major breakout for this stock. It ran through support and the all-time high level from back in 2007 on its way to a spike up at 33.40. There’s resistance here, and if it follows through here, I could see this stock in the high 30’s.
Stocks on the long side included Ambarella, Inc. (AMBA), Advanced Micro Devices, Inc. (NASDAQ:AMD), American Superconductor Corporation (AMSC), Apellis Pharmaceuticals, Inc. (APLS), argenx SE (ARGX), AudioCodes Ltd. (AUDC), Biohaven Pharmaceutical Holding Company Ltd. (BHVN), CareDx, Inc (CDNA), Coupa Software Incorporated (COUP), Etsy, Inc. (ETSY), Exact Sciences Corporation (EXAS), Exelixis, Inc. (EXEL), Fate Therapeutics, Inc. (FATE), First Solar, Inc. (NASDAQ:FSLR), Global Blood Therapeutics, Inc. (GBT), Direxion Daily S&P Biotech Bull 3X ETF (LABU), RiceBran Technologies (RIBT), TAL Education Group (TAL), Vericel Corporation (VCEL), Veracyte, Inc. (VCYT), Vanda Pharmaceuticals Inc. (VNDA), and Xilinx, Inc. (NASDAQ:XLNX).
Watch video here.